A detailed history of Quadrant Capital Group LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 802 shares of ARWR stock, worth $15,205. This represents 0.0% of its overall portfolio holdings.

Number of Shares
802
Previous 410 95.61%
Holding current value
$15,205
Previous $10,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$19.36 - $29.54 $7,589 - $11,579
392 Added 95.61%
802 $15,000
Q2 2024

Aug 12, 2024

BUY
$21.87 - $28.24 $3,236 - $4,179
148 Added 56.49%
410 $10,000
Q1 2024

May 15, 2024

BUY
$27.21 - $39.48 $625 - $908
23 Added 9.62%
262 $7,000
Q4 2023

Feb 08, 2024

SELL
$21.2 - $31.03 $3,625 - $5,306
-171 Reduced 41.71%
239 $7,000
Q3 2023

Nov 14, 2023

SELL
$26.2 - $36.08 $8,986 - $12,375
-343 Reduced 45.55%
410 $11,000
Q2 2023

Aug 09, 2023

SELL
$25.16 - $41.38 $2,490 - $4,096
-99 Reduced 11.62%
753 $26,000
Q1 2023

May 11, 2023

SELL
$23.68 - $38.51 $3,078 - $5,006
-130 Reduced 13.24%
852 $21,000
Q4 2022

Feb 10, 2023

BUY
$28.0 - $40.56 $14,140 - $20,482
505 Added 105.87%
982 $39,000
Q3 2022

Nov 10, 2022

BUY
$29.63 - $48.31 $8,148 - $13,285
275 Added 136.14%
477 $16,000
Q2 2022

Aug 09, 2022

SELL
$27.79 - $50.61 $333 - $607
-12 Reduced 5.61%
202 $7,000
Q1 2022

May 06, 2022

SELL
$39.62 - $69.97 $9,350 - $16,512
-236 Reduced 52.44%
214 $10,000
Q4 2021

Feb 01, 2022

BUY
$58.09 - $82.51 $8,306 - $11,798
143 Added 46.58%
450 $30,000
Q3 2021

Nov 12, 2021

BUY
$58.38 - $84.96 $525 - $764
9 Added 3.02%
307 $19,000
Q2 2021

Aug 09, 2021

SELL
$62.15 - $90.32 $7,085 - $10,296
-114 Reduced 27.67%
298 $25,000
Q1 2021

May 12, 2021

BUY
$61.35 - $90.47 $490 - $723
8 Added 1.98%
412 $27,000
Q4 2020

Feb 16, 2021

BUY
$43.82 - $85.37 $6,573 - $12,805
150 Added 59.06%
404 $31,000
Q3 2020

Nov 13, 2020

BUY
$33.21 - $51.27 $797 - $1,230
24 Added 10.43%
254 $11,000
Q2 2020

Aug 13, 2020

BUY
$26.12 - $43.27 $4,884 - $8,091
187 Added 434.88%
230 $10,000
Q1 2020

May 15, 2020

SELL
$20.56 - $63.12 $6,805 - $20,892
-331 Reduced 88.5%
43 $1,000
Q4 2019

Feb 03, 2020

BUY
$28.14 - $73.01 $7,513 - $19,493
267 Added 249.53%
374 $21,000
Q3 2019

Oct 24, 2019

BUY
$26.26 - $34.86 $1,339 - $1,777
51 Added 91.07%
107 $2,000
Q2 2019

Jul 24, 2019

BUY
$17.43 - $28.82 $976 - $1,613
56 New
56 $1,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.01B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.